Navigation Links
Sirtex To Distribute Surefire Medical's Innovative Infusion System in Australia and Asia Pacific Markets
Date:6/20/2013

SYDNEY and WESTMINSTER, Colo., June 20, 2013 /PRNewswire/ -- Sirtex Medical Limited (ASX: SRX) and US-based Surefire Medical today announced a sales and marketing partnership to distribute Surefire's range of innovative infusion systems and specialty catheters for the interventional radiology and oncology markets.

The agreement will see Sirtex exclusively distribute the Surefire Medical range of products in the company's rapidly growing Asia Pacific markets including Australia.

Sirtex reported a 30 per cent growth in dose sales of its targeted radiation treatment for liver cancer in the Asia Pacific region at the end of the third quarter ended 31 March 2013.

Rapidly growing Surefire Medical has received regulatory approval in the U.S., Europe, Canada and New Zealand.  Its first-in-class infusion systems are used by numerous top-ranked cancer centers and hospitals in these markets.

The Surefire Infusion System has been designed to enhance the accuracy and delivery of drugs directly to tumors.  Surefire products use a patented microcatheter with an expandable tip. When deployed, the tip dynamically responds to flow conditions to enable more of the embolic agent to reach the intended destination while reducing non-target delivery compared to traditional infusion systems.

The ability to more safely and efficiently deliver embolic agents directly to target tumors marks a significant advance in radiation oncology procedures and in the treatment of liver cancer.

Sirtex Medical Asia Pacific Chief Executive Officer Dr. Burwood Chew said, "Sirtex is constantly looking for new ways to help our customers improve the outcomes of their patients with liver cancer.  We believe this distribution partnership will allow us to provide interventional radiologists and oncologists with a wider range of options that may potentially lead to improved patient outcomes, which is our shared goal."

Surefire Medical CEO Jim Chomas said, "A growing body of positive clinical evidence and the enthusiasm of our increasing user base at hospitals worldwide continue to prove the efficacy of the Surefire line of infusion systems.  The agreement with Sirtex enables our companies to jointly pursue more effective treatment for the rising worldwide incidence of liver cancer."

For further information please refer to www.surefiremedical.com and sirtex.com  

SIR-Spheres® is a registered trademark of Sirtex SIR-Spheres Pty Ltd.


'/>"/>
SOURCE Surefire Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Independent Pharmacy Cooperative to Distribute Promescent, Topical Medication for Premature Ejaculation
2. Green Valley Drugs Announces Voluntary Nationwide Recall Of All Lots Of All Sterile Products Compounded, Repackaged, And Distributed By Green Valley Drugs Due To Quality Control Concerns
3. Sigma-Aldrich Corporations Sigma Life Science Business to Distribute Worldwide Olink Biosciences Protein Interaction Analysis Technology
4. GHX Selects MicroStrategy to Offer Healthcare Suppliers Enhanced Access to Distributed Medical-Surgical Market Data
5. Sectra Signs Agreement to Distribute its Breast Imaging PACS With Integrated Cad Software
6. Sectra Signs Agreement to Distribute its Breast Imaging PACS With Integrated Volpara Breast Density Software
7. Surefire Infusion System Used In Potential New Hunger-Reducing Obesity Treatment -- NIH Funds Johns Hopkins Study
8. Study: Surefire Medicals Technology Improves Delivery Of Embolics In Cancer Treatment
9. Surefire Medical, Inc.: Gene McGrevin Joins Surefire Medicals Board of Directors
10. Christopher Mennone Joins Surefire Medical Team As International Business Director
11. Surefire Medicals Infusion System For Embolization Procedures Receives CE Mark Approval
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... Texas , May 25, 2016 ... the issuance to it by the US Patent ... The company,s technology includes proprietary processes for electronic ... for health and wellness programs, HIPAA compliance and ... "Our technology ...
(Date:5/25/2016)... 25, 2016 ReportsnReports.com adds ... report that provides an overview on therapeutic pipeline ... various stages, therapeutics assessment by drug target, mechanism ... molecule type, along with latest updates, and featured ... players involved in the therapeutic development for Chronic ...
(Date:5/24/2016)... LONDON , May 24, 2016 ... erfüllt beide primären Endpunkte ... und Überlegenheit in ‚ausgezeichneter plus guter ... aufsteigenden Colons    ,      (Logo: ... B.V. gab heute neue positive Daten von der ...
Breaking Medicine Technology:
(Date:5/28/2016)... ... 28, 2016 , ... "Color Grading media can be time consuming but with ... media," said Christina Austin - CEO of Pixel Film Studios. , With the ... stylish color grades to their footage. A LUT is a Lookup Table that contains ...
(Date:5/28/2016)... , ... May 28, 2016 , ... In a part of the city where’s it’s ... new farm-to-table Kelowna restaurants is hoping to attract diners with a taste for ... Suites officially opened the doors to Cornerstone Grill, an urban casual restaurant focusing on ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... Two director-level ... as YWCA Tribute to Women and Industry (TWIN) 2016 honorees. The award recognizes ... workplace. For this year, Geri Boone, Director of the MLTSS (Managed Long-Term Services and ...
(Date:5/27/2016)... ... May 27, 2016 , ... With over 60 percent of acute ... for a sustainable product to aid in the rehabilitation process has steadily increased. Ekso ... of individuals with hemiplegia due to stroke. , Ekso Bionics has now received clearance ...
(Date:5/27/2016)... ... May 27, 2016 , ... In response ... many who are unaware of the plight of aphasia. In collaboration with the ... “Stroke Awareness” campaign. , The link between stroke and aphasia is relatively unknown, ...
Breaking Medicine News(10 mins):